Back to Markets
CLCellectis SA

Cellectis SA

CLLSNYSE EURONEXT - EURONEXT PARIS
Health CareBiotechnology

$3.52

-0.110000 (-3.03%)

As of 05/29/26 EDT · USD

Compare
Low: $1.33Current: $3.52High: $5.48

Key Statistics

Open

$3.62

Day High

$3.63

Day Low

$3.52

Prev. Close

$3.63

VolumeShares traded today.

51.56K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$253.77M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-5.26

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$5.48

52W LowLowest price over the past 52 weeks.

$1.33

50D MAAverage closing price over the last 50 trading days.

$3.72

200D MAAverage closing price over the last 200 trading days.

$3.79

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+0.0%

1M

-5.6%

6M

-32.8%

YTD

-26.7%

1Y

+136.2%

About

André Choulika is a biotechnologist, the inventor of nuclease-based genome editing and a pioneer in the analysis and use of meganucleases to modify complex genomes.

www.cellectis.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNYSE EURONEXT - EURONEXT PARIS
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade CLLS

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.